Cleared Traditional

K853901 - ENDO-LASE CD 40 FOR DERMATOLOGY

K853901 is the FDA 510(k) clearance for ENDO-LASE CD 40 FOR DERMATOLOGY by Endo Lase, Inc.. It is a Class 2 General & Plastic Surgery device (product code GEX) cleared through the Traditional 510(k) pathway after a 152-day FDA review.

K853901 · Endo Lase, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1986
Decision
152d
Days
Class 2
Risk

K853901 is an FDA 510(k) clearance for the ENDO-LASE CD 40 FOR DERMATOLOGY. Classified as Powered Laser Surgical Instrument within the GEX classification (a category for powered laser surgical instruments across multiple specialties), Class II - Special Controls.

Submitted by Endo Lase, Inc. (Washington, US). The FDA issued a Cleared decision on February 19, 1986 after a review of 152 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Endo Lase, Inc. devices

Submission Details

510(k) Number K853901 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 20, 1985
Decision Date February 19, 1986
Days to Decision 152 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
37d slower than avg
Panel avg: 115d · This submission: 152d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GEX Powered Laser Surgical Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition A Laser (light Amplification By Stimulated Emission Of Radiation) Based Device Having Coherence, Collimated And Typically Monochromatic Radiation. Typically Indicated To To Cut, Destroy, Remove Or Coagulate Tissue, Generally Soft Tissue, For General Surgical Purpose In Medical Specialties Of General And Plastic Surgery, Dermatology/aesthetic, Podiatry, Otolaryngology (ent), Gynecology, Neurosurgery, Orthopedics (soft Tissue), Dental And Oral Surgery, And Dentistry. The Classification Regulation 21 Cfr 878.4810 Describes A Device That Is Carbon Dioxide Or Argon Laser Intended To Cut, Destroy, Remove Or Coagulate Tissue By The Light.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GEX Powered Laser Surgical Instrument

All 740
Devices cleared under the same product code (GEX) and FDA review panel - the closest regulatory comparables to K853901.
MODIFIED MODEL 2100 ND:YAG LASER
K881848 · Sharplan Lasers, Inc. · May 1988
CODMAN NEUROLASE LASER SYSTEM
K872179 · Codman & Shurtleff, Inc. · Oct 1987
SHARPLAN MODEL 1020 CO2 SURGICAL LASER SYSTEM
K860087 · Sharplan Lasers, Inc. · Apr 1986
CODMAN LASER BACKSTOP
K853626 · Codman & Shurtleff, Inc. · Feb 1986
CODMAN LASER RODS
K853627 · Codman & Shurtleff, Inc. · Feb 1986
MINI-HALO CO2 LASER SYSTEM
K843915 · CooperVision, Inc. · May 1985